MA MAXHEALTH
Max Healthcare Institute Q1 2026
MAMAXHEALTH

Max Healthcare Institute Q1 FY26 results (Apr–Jun 2025) and concall

Healthcare · Concall AI · Call held 14 Aug 2025

Management summary

  • Max Healthcare delivered strong Q1 FY26 performance with robust growth metrics, extending its growth streak to 19 consecutive quarters.
  • The results demonstrate successful execution of acquisition integration and expansion strategy.

Source: Inve concall analysis and management guidance record.

What they filed

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26
Revenue1,868 1,910 2,028
EBITDA499 512 523
Net profit239 319 308
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Unlock risks & concerns, Q2 FY26 watchlist, and full call analysis

You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:

  • Risks, concerns & management red flags
  • Watchlist triggers for Q2 FY26
  • Full section-by-section call narrative

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image